Your browser doesn't support javascript.
loading
IPH4102, a humanized KIR3DL2 antibody with potent activity against cutaneous T-cell lymphoma.
Marie-Cardine, Anne; Viaud, Nicolas; Thonnart, Nicolas; Joly, Rachel; Chanteux, Stéphanie; Gauthier, Laurent; Bonnafous, Cécile; Rossi, Benjamin; Bléry, Mathieu; Paturel, Carine; Bensussan, Armand; Bagot, Martine; Sicard, Hélène.
Afiliação
  • Marie-Cardine A; INSERM U976, Hôpital Saint Louis, Paris, France. University Paris Diderot, Sorbonne Paris Cité, UMRS 976, Paris, France. helene.sicard@innate-pharma.fr anne.marie-cardine@inserm.fr.
  • Viaud N; INNATE PHARMA, Marseilles, France.
  • Thonnart N; INSERM U976, Hôpital Saint Louis, Paris, France. University Paris Diderot, Sorbonne Paris Cité, UMRS 976, Paris, France.
  • Joly R; INNATE PHARMA, Marseilles, France.
  • Chanteux S; INNATE PHARMA, Marseilles, France.
  • Gauthier L; INNATE PHARMA, Marseilles, France.
  • Bonnafous C; INNATE PHARMA, Marseilles, France.
  • Rossi B; INNATE PHARMA, Marseilles, France.
  • Bléry M; INNATE PHARMA, Marseilles, France.
  • Paturel C; INNATE PHARMA, Marseilles, France.
  • Bensussan A; INSERM U976, Hôpital Saint Louis, Paris, France. University Paris Diderot, Sorbonne Paris Cité, UMRS 976, Paris, France.
  • Bagot M; INSERM U976, Hôpital Saint Louis, Paris, France. University Paris Diderot, Sorbonne Paris Cité, UMRS 976, Paris, France. AP-HP, Hôpital Saint Louis, Department of Dermatology, Paris, France.
  • Sicard H; INNATE PHARMA, Marseilles, France. helene.sicard@innate-pharma.fr anne.marie-cardine@inserm.fr.
Cancer Res ; 74(21): 6060-70, 2014 Nov 01.
Article em En | MEDLINE | ID: mdl-25361998

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article